Short

Adicet Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Friday, September 18, 2020 - 9:10pm

On September 16, 2020, Adicet announced the appointment of Mr. Harvey as Chief Financial Officer responsible for leading the companys financial strategy and management of activities related to accounting, capital markets and business operations.

Key Points: 
  • On September 16, 2020, Adicet announced the appointment of Mr. Harvey as Chief Financial Officer responsible for leading the companys financial strategy and management of activities related to accounting, capital markets and business operations.
  • The Harvey Stock Option was issued as an inducement non-qualified stock option, pursuant to Rule 5635(c)(4) of the NASDAQ Listing Rules, as an inducement material to Mr. Harvey entering into employment with Adicet.
  • The Harvey Stock Option is subject to the terms and conditions of the form of award agreement covering the grant.
  • Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases.

Cardlytics Announces Pricing of Offering of $200 Million of Convertible Senior Notes

Friday, September 18, 2020 - 12:00pm

Cardlytics also granted the initial purchasers of the notes an option to purchase up to an additional $30 million principal amount of notes.

Key Points: 
  • Cardlytics also granted the initial purchasers of the notes an option to purchase up to an additional $30 million principal amount of notes.
  • The notes will be convertible under certain circumstances into cash, shares of Cardlytics common stock or a combination of cash and shares of Cardlytics common stock, at Cardlytics election.
  • If Cardlytics elects to redeem less than all of the notes, at least $75.0 million aggregate principal amount of notes must be outstanding and not subject to redemption as of the relevant redemption notice date.
  • The capped call transactions cover, subject to customary adjustments, the number of shares of Cardlytics common stock that will initially underlie the notes.

Marathon Patent Group Withdraws Offer to Acquire Fastblock Mining; Companies Unable to Reach  Long-Term Power Agreement at Acceptable Rates

Thursday, September 17, 2020 - 9:15pm

LAS VEGAS, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Marathon Patent Group, Inc. (NASDAQ: MARA ) ("Marathon" or "Company"), today announced that as of September 11th, 2020, the Company has withdrawn its offer to acquire Fastblock Mining.

Key Points: 
  • LAS VEGAS, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Marathon Patent Group, Inc. (NASDAQ: MARA ) ("Marathon" or "Company"), today announced that as of September 11th, 2020, the Company has withdrawn its offer to acquire Fastblock Mining.
  • During its due diligence process, the Company discovered that the Power Agreement pursuant to which Fastblock would provide power at a subsidized rate of $0.0285KwH, would expire in three years.
  • In that event, the value of our securities could decline, and you could lose part or all of your investment.
  • The Company assumes no obligation to update or supplement forward-looking statements that become untrue because of subsequent events, new information or otherwise.

Strongbridge Biopharma plc Investors: Company Investigated by the Portnoy Law Firm

Thursday, September 17, 2020 - 1:00pm

LOS ANGELES, Sept. 17, 2020 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Strongbridge Biopharma plc ("Strongbridge" or the "Company") (NYSE: SBBP) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.

Key Points: 
  • LOS ANGELES, Sept. 17, 2020 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Strongbridge Biopharma plc ("Strongbridge" or the "Company") (NYSE: SBBP) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors options for pursuing claims to recover their losses.
  • A press release was issued by Strongbridge on September 8th, 2020, entitled "Strongbridge Biopharma's Recorlev successful in Cushing's syndrome study."
  • The Portnoy Law Firm represents investors in pursuing claims arising from corporate wrongdoing.

Reinvent Technology Partners Announces Pricing of $600 Million Initial Public Offering

Thursday, September 17, 2020 - 12:06am

Reinvent Technology Partners (the Company) announced today that it priced its initial public offering of 60,000,000 units at $10.00 per unit.

Key Points: 
  • Reinvent Technology Partners (the Company) announced today that it priced its initial public offering of 60,000,000 units at $10.00 per unit.
  • Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share.
  • The Company has granted the underwriter a 45-day option to purchase up to an additional 9,000,000 units at the initial public offering price to cover over-allotments, if any.
  • This press release contains statements that constitute forward-looking statements, including with respect to the proposed initial public offering.

Executive Network Partnering Corporation Announces Pricing of Upsized $360 Million Initial Public Offering

Wednesday, September 16, 2020 - 1:37pm

Executive Network Partnering Corporation (the Company), a company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar partnering transaction with one or more businesses, today announced the pricing of its initial public offering of 14,400,000 CAPS at a price of $25.00 per CAPS.

Key Points: 
  • Executive Network Partnering Corporation (the Company), a company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar partnering transaction with one or more businesses, today announced the pricing of its initial public offering of 14,400,000 CAPS at a price of $25.00 per CAPS.
  • Each CAPS consists of one share of Class A common stock of the Company and one-quarter of one warrant.
  • The Company has granted the underwriter a 45-day option to purchase up to an additional 2,160,000 CAPS at the initial public offering price to cover over-allotments, if any.
  • This press release contains statements that constitute forward-looking statements, including with respect to the proposed initial public offering and the anticipated use of the net proceeds.

Sandbridge Acquisition Corporation Announces Pricing of $200 Million Initial Public Offering

Tuesday, September 15, 2020 - 5:09am

Sandbridge Acquisition Corporation (the Company) today announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit.

Key Points: 
  • Sandbridge Acquisition Corporation (the Company) today announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit.
  • Each whole warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share.
  • The Company has granted the underwriters a 45-day option to purchase up to 3,000,000 additional units at the initial public offering price to cover over-allotments, if any.
  • The public offering is being made only by means of a prospectus.

Nikola Sets the Record Straight on False and Misleading Short Seller Report

Monday, September 14, 2020 - 12:00pm

These allegations by the short seller are false and misleading, and designed to manipulate the market to profit from a manufactured decline in Nikola's stock price.

Key Points: 
  • These allegations by the short seller are false and misleading, and designed to manipulate the market to profit from a manufactured decline in Nikola's stock price.
  • These allegations by the short seller are false and misleading, and designed to manipulate the market to profit from a manufactured decline in Nikola's stock price.
  • These allegations by the short seller are false and misleading, and designed to manipulate the market to profit from a manufactured decline in Nikola's stock price.
  • Short Seller Takes Shots at Nikola Employees: Nikola believes in talent, and each of the employees unfairly described in the short seller report are making important contributions to the success of the Company.

PURA Upcoming Dividend Garners $0.015 12-Month Target Value

Friday, September 11, 2020 - 4:13pm

DALLAS, Sept. 11, 2020 /PRNewswire/ --Puration, Inc. (USOTC: PURA) today announced recent analyst research pertaining to the upcoming planned shareholder dividend for prompt distribution where shareholders are to receive one share of PAO Group, Inc. (USOTC: PAOG) for every PURA share held.

Key Points: 
  • DALLAS, Sept. 11, 2020 /PRNewswire/ --Puration, Inc. (USOTC: PURA) today announced recent analyst research pertaining to the upcoming planned shareholder dividend for prompt distribution where shareholders are to receive one share of PAO Group, Inc. (USOTC: PAOG) for every PURA share held.
  • Goldman Small Cap Research earlier this week released an update to a previous research report covering PAOG's cannabis biopharmaceutical business.
  • A second shareholder dividend is in the works and the transaction that would result in the dividend issuance is anticipated to be complete by the end of this month.
  • PURA management would in turn issue the purchase stock to PURA shareholders through a dividend distribution similarly to the dividend distribution underway in conjunction with PURA's recent sale of its cannabis cultivation assets to PAOG.

Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date August 31, 2020

Thursday, September 10, 2020 - 9:05pm

The end-of-August short interest represent 3.54 days average daily Nasdaq Global Market share volume for the reporting period, compared with 3.04 days for the prior reporting period.

Key Points: 
  • The end-of-August short interest represent 3.54 days average daily Nasdaq Global Market share volume for the reporting period, compared with 3.04 days for the prior reporting period.
  • Short interest in 1,082 securities on The Nasdaq Capital MarketSM totaled 1,272,016,633 shares at the end of the settlement date of August 31, 2020 compared with1,217,698,749 shares in 1,078 securities for the previous reporting period.
  • The open short interest positions reported for each Nasdaq security reflect the total number of shares sold short by all broker/dealers regardless of their exchange affiliations.
  • For more information on Nasdaq Short interest positions, including publication dates, visit
    Nasdaq (Nasdaq: NDAQ) is a global technology company serving the capital markets and other industries.